<DOC>
	<DOCNO>NCT02642471</DOCNO>
	<brief_summary>The diagnostic value sentinel lymph node biopsy early-stage cervical cancer well study . However , randomize control study compare long-term outcome sentinel lymph node biopsy conventional procedure . The investigator perform phase III , randomize control trial determine whether pelvic lymphadenectomy could replace sentinel lymph node biopsy surgical treatment patient early-stage cervical cancer .</brief_summary>
	<brief_title>Sentinel Lymph Node Biopsy Versus Systematic Pelvic Lymphadenectomy Early-stage Cervival Cancer</brief_title>
	<detailed_description>This study comprise two part : Part I : To compare outcomes management without pelvic lymphadenectomy patient negative sentinel lymph node ; Part II : To compare outcomes management without pelvic lymphadenectomy patient positive sentinel lymph node . Patients newly diagnose International Federation Gynecology Obstetrics ( FIGO ) stage IA2 , IB1 IIA1 cervical cancer eligible study . The tumor diameter less 3cm . Sentinel lymph node biopsy perform begin operation . After pathological examination frozen section , patient assign Part I Part II study accord status sentinel node . In part trail , patient equal chance randomly assign experimental arm ( undergo radical hysterectomy plus systematic pelvic lymphadenectomy ) control arm ( undergo radical hysterectomy ) . Postoperative pelvic radiotherapy start within 6 week surgery patient pelvic lymph node metastasis , parametrial involvement , deep stromal invasion positive margin . Extended-field external beam therapy , deliver dose 4500cGy four-field technique , administer patient positive para-aortic node . High-dose rate brachytherapy deliver vaginal stump patient positive surgical margin . The primary end point 2-years progression-free survival . The secondary end point overall survival , long-term outcome sentinel lymph node biopsy quality life .</detailed_description>
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<criteria>Patients newly histologically confirm cervical carcinoma Histopathology squamaous carcinoma , adenocarcinoma adenosquamous carcinoma Original clinical stage must IA2 , IB1 IIA1 （FIGO ) Age 1865 Patients must give sign informed consent P.S status : 01 Estimated survival time ＞ 3 month Tumor diameter ≤ 3 cm The presence uncontrolled lifethreatening illness Receiving way anticancer therapy Investigator consider patient ca n't finish whole study With normal liver function test ( ALT、AST &gt; 2.5×ULN ) With normal renal function test ( Creatinine &gt; 1.5×ULN ) WBC &lt; 4,000/mm3 PLT &lt; 100,000/mm</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>sentinel lymph node</keyword>
	<keyword>pelvic lymphadenectomy</keyword>
	<keyword>cervical carcinoma</keyword>
	<keyword>surgery</keyword>
	<keyword>radiotherapy</keyword>
</DOC>